InnoCyte GmbH Finds Further Investors

26-Nov-2012 - Germany

InnoCyte GmbH has won three renowned investors for their cause: In a first round of financing, High-Tech Gründerfonds (HTGF), the Mittelständische Beteiligungsgesellschaft (MBG) – within the framework of the Seedfonds Baden-Württemberg – and Fraunhofer Venture have increased the capital of the young GmbH by a high six-figure amount. The goal is to push growth and further advance the technology.

InnoCyte GmbH has developed a technology that standardizes, automates, accelerates and therefore significantly simplifies and reduces the cost of producing biological cells. The cell production as such is a key process in biological and medical research, for example in the development of medication („pharma screening“) or when creating artificial tissue („tissue engineering“).

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...